Neurology
RSSArticles
-
Safely Centralized Telemetry Off-site in a Multi-hospital System
SYNOPSIS: The hospitals in this study outsourced their cardiac telemetry to an off-site central monitoring center without an increase in adverse events.
-
What If Beats 5 and 8 Had Children?
The easiest way to approach the interpretation of more challenging arrhythmias such as this one is to begin with the part of the tracing that is most evident and save the most difficult part for last.
-
Clinical Briefs
In this section: water aerobics for overweight and hypertensive women; topicals for atopic dermatitis; removing ticks successfully.
-
Etanercept-szzs Injection (Erelzi)
Etanercept-szzs is indicated for moderate to severe active rheumatoid arthritis, moderate to severe active polyarticular juvenile idiopathic arthritis, psoriatic arthritis, active ankylosing spondylitis, and chronic moderate to severe plaque psoriasis.
-
Calcium Supplementation and Increased Dementia Risk
In this five-year observational study, women who were taking calcium supplementation and who presented with pre-existing cerebrovascular disease were at higher risk of dementia than women not taking extra calcium.
-
Screening for Coronary Artery Disease Is Underused in Heart Failure
In a large retrospective cohort of patients hospitalized for new-onset heart failure, the majority did not receive testing for ischemic heart disease.
-
How Much More Physical Activity Helps Patients Avoid Chronic Diseases?
Higher levels of total physical activity are strongly associated with lower risk of five common chronic diseases: breast and bowel cancer, diabetes, heart disease, and stroke.
-
Zika Virus Infection and Guillain-Barré Syndrome
Guillain-Barré syndrome is a defined complication of Zika virus infection and presents in a typical manner, similar to other post-viral GBS syndromes.
-
Headaches in the Elderly: A Non-specific Marker for Stroke Risk
Non-migrainous headaches, for which there are many causes, appear to be a risk factor for stroke in an elderly population, but the mechanism is uncertain.
-
Disease Rebound After Stopping Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis
A review of patients with relapsing-remitting multiple sclerosis who discontinued fingolimod therapy showed that five out of 46 (10.9 %) of these patients developed a rebound phenomenon between 4 to 16 weeks, where disease activity returns and often exceeds pre-treatment levels.